A single-cell atlas of diffuse large B cell lymphoma

Area of Science:

• Oncology
• Immunology
• Genomics

Background:

• Diffuse Large B Cell Lymphoma (DLBCL) is an aggressive B cell malignancy with a significant proportion of patients remaining incurable.
• Understanding the cellular heterogeneity and tumor microenvironment is crucial for developing effective treatments.

Purpose of the Study:

• To comprehensively profile the cellular and molecular landscape of DLBCL using single-cell RNA sequencing.
• To identify gene expression programs, cell-cell interactions, and immune evasion mechanisms within the DLBCL tumor microenvironment.

Main Methods:

• Single-cell RNA sequencing was performed on 94,324 cells from 17 DLBCL and 3 control samples.
• Transcriptomic data was analyzed to identify gene expression programs and predict cell-cell interactions.

Main Results:

• 73 distinct gene expression programs were identified in malignant DLBCL cells, highlighting significant intra- and inter-tumor heterogeneity.
• 2,754 potential cell-cell interactions were predicted, revealing a dynamic tumor microenvironment.
• A CD70-CD27 interaction between malignant and T cells was noted, alongside evidence of T cell exhaustion driven by TIM3 and TIGIT signaling.
• Chronic hepatitis B virus infection was associated with tumor cell survival and immune evasion in DLBCL.

Conclusions:

• The study provides a detailed molecular map of DLBCL, uncovering critical insights into lymphomagenesis.
• Identified interactions and immune evasion pathways offer potential targets for novel immunotherapy strategies.
• Findings underscore the role of the tumor microenvironment and viral infections in DLBCL progression.